Authors: Prince, HM Rischin, D Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Quinn, M Brettell, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P

Citation: Hm. Prince et al., Repetitive high-dose therapy with cyclophosphamide, thiotepa and docetaxelwith peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: results of a phase I study, BONE MAR TR, 26(9), 2000, pp. 955-961

Authors: Prince, HM Toner, GC Seymour, JF Blakey, D Gates, P Eerhard, S Chapple, P Wall, D Quinn, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P Brettell, M Rischin, D

Citation: Hm. Prince et al., Docetaxel effectively mobilizes peripheral blood CD34(+) cells, BONE MAR TR, 26(5), 2000, pp. 483-487

Authors: Prince, HM Millward, MJ Rischin, D Blakey, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Seymour, JF Brettell, M Strickland, A Zalcberg, J Richardson, G Scarlett, J Briggs, P Toner, GC

Citation: Hm. Prince et al., Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel withperipheral blood progenitor cell and filgrastim support for metastatic andlocally advanced breast cancer: Results of a phase I study, ANN ONCOL, 10(4), 1999, pp. 479-481

Authors: Wilke, R Brettell, M Prince, HM Wolf, M McKenna, R Serpell, E Molloy, M Stevens, H Quinn, M Gates, P Chapple, P

Citation: R. Wilke et al., Comparison of COBE (R) Spectra (TM) software version 4.7 PBSC and version 6.0 auto PBSC (TM) program, J CLIN APH, 14(1), 1999, pp. 26-30

Authors: Prince, HM Gardyn, J Millward, MJ Rischin, D Francis, P Gates, P Chapple, P Quinn, M Juneja, S Wolf, M Januszewicz, EH Richardson, G Scarlett, J Briggs, P Brettell, M Toner, GC

Citation: Hm. Prince et al., Ifosfamide in combination with paclitaxel or doxorubicin: regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer, BONE MAR TR, 23(5), 1999, pp. 427-435